New study below.
It will be used by the naysayers, but ponder this:
"The study population of 217,244 individuals had a median vitamin D level of 46 nmol/L."
i.e. the median was 18 ng/mL.
Most papers I have seen give 20 ng/mL as the cutoff for deficiency. So more than half of the population was deficient.
One has to admire the audacity of Nordic researchers who continue to engage in vitamin D studies on populations where it is impossible to avoid deficiency in winter, except by supplementing (& many clearly don't).
The word "higher" is used 4 times in the Abstract, but don't cofuse it with "high" in this population.
-Patrick
ncbi.nlm.nih.gov/pubmed/306...
Int J Cancer. 2019 Jan 7. doi: 10.1002/ijc.32105. [Epub ahead of print]
Vitamin D levels and Cancer Incidence in 217.244 individuals from Primary Health Care in Denmark.
Vojdeman FJ1, Madsen CM2, Frederiksen K3, Durup D4, Olsen A3, Hansen L3, Heegaard AM4,5, Lind B6, Tjønneland A3,5, Jørgensen HL6,5, Schwarz P7,5.
Author information
Abstract
Vitamin D has been linked to cancer development in both pre-clinical and epidemiological studies. This study examines the association between serum levels of vitamin D and cancer incidence in the Capital Region of Denmark. Individuals who had vitamin D analyzed at The Copenhagen General Practitioners Laboratory between April 2004 and January 2010 were linked to Danish registries with end of follow-up date at Dec 31st 2014, excluding individuals with pre-existing cancer. Cox regression models adjusted for age in one-year intervals, sex, month of sampling, and Charlson Comorbidity Index were applied. The study population of 217,244 individuals had a median vitamin D level of 46 nmol/L (IQR 27-67 nmol/L). Non-melanoma skin cancer was the most frequent form of cancer, followed by breast-, lung-, and prostate cancers. No associations were found between increments of 10nmol/L vitamin D and incidence of breast, colorectal, urinary, ovary or corpus uteri cancer. However, higher levels of vitamin D were associated with higher incidence of non-melanoma (HR 1.09 [1.09-1.1]) and melanoma skin cancer (HR 1.1 [1.08-1.13]) as well as prostate (HR 1.05 [1.03-1.07]) and hematological cancers (HR 1.03 [1.01-1.06]), but with lower incidence of lung cancer (HR 0.95 [0.93-0.97]). In this study, vitamin D levels are not associated with the incidence of several major cancer types, but higher levels are significantly associated with a higher incidence of skin, prostate, and hematological cancers as well as a lower incidence of lung cancer. These results do not support an overall protective effect against cancer by vitamin D. This article is protected by copyright. All rights reserved.
KEYWORDS:
cancer incidence; primary health care; vitamin D levels
PMID: 30613979 DOI: 10.1002/ijc.32105